Cargando…

Concurrent whole brain radiotherapy and bortezomib for brain metastasis

BACKGROUND: Survival of patients with brain metastasis particularly from historically more radio-resistant malignancies remains dismal. A phase I study of concurrent bortezomib and whole brain radiotherapy was conducted to determine the tolerance and safety of this approach in patients with previous...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lao, Christopher D, Friedman, Judah, Tsien, Christina I, Normolle, Daniel P, Chapman, Christopher, Cao, Yue, Lee, Oliver, Schipper, Matt, Van Poznak, Catherine, Hamstra, Daniel, Lawrence, Theodore, Hayman, James, Redman, Bruce G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3765365/ https://www.ncbi.nlm.nih.gov/pubmed/23965287 http://dx.doi.org/10.1186/1748-717X-8-204

Ejemplares similares

TRLS-07. BRAINSTORM: OUTCOMES FROM A MULTI-INSTITUTIONAL PHASE I/II STUDY OF RRx-001 IN COMBINATION WITH WHOLE BRAIN RADIATION THERAPY FOR PATIENTS WITH BRAIN METASTASES
por: Kim, Michelle, et al.
Publicado: (2019)

Whole Brain Radiotherapy and RRx-001: Two Partial Responses in Radioresistant Melanoma Brain Metastases from a Phase I/II Clinical Trial()(): A TITE-CRM Phase I/II Clinical Trial
por: Kim, Michelle M., et al.
Publicado: (2016)

Regional Variation in Brain White Matter Diffusion Index Changes following Chemoradiotherapy: A Prospective Study Using Tract-Based Spatial Statistics
por: Chapman, Christopher H., et al.
Publicado: (2013)

Whole brain radiotherapy for brain metastasis
por: McTyre, Emory, et al.
Publicado: (2013)

Unilateral Cervical Polyneuropathies following Concurrent Bortezomib, Cetuximab, and Radiotherapy for Head and Neck Cancer
por: Elghouche, Alhasan, et al.
Publicado: (2016)

Toxic epidermal necrolysis in a patient receiving concurrent phenytoin and whole brain and thoracic radiotherapy
por: Ahmed, Imtiaz, et al.
Publicado: (2014)

Whole brain radiotherapy with radiosensitizer for brain metastases
por: Viani, Gustavo Arruda, et al.
Publicado: (2009)

Phase I Trial of Radiotherapy Concurrent with Twice-Weekly Gemcitabine for Head and Neck Cancer: Translation From Preclinical Investigations Aiming to Improve the Therapeutic Ratio()()
por: Popovtzer, Aron, et al.
Publicado: (2014)

Ipilimumab and radiation therapy for melanoma brain metastases
por: Silk, Ann W, et al.
Publicado: (2013)

Whole Brain Radiotherapy Plus Concurrent Chemotherapy in Non-Small Cell Lung Cancer Patients with Brain Metastases: A Meta-Analysis
por: Qin, Hong, et al.
Publicado: (2014)

Brain Radiotherapy plus Concurrent Temozolomide versus Radiotherapy Alone for Patients with Brain Metastases: A Meta-Analysis
por: Zhao, Qian, et al.
Publicado: (2016)

Concurrent versus sequential whole brain radiotherapy and TKI in EGFR-mutated NSCLC patients with brain metastasis: A single institution retrospective analysis
por: Chen, Hualin, et al.
Publicado: (2018)

A pilot study of concurrent whole-brain radiotherapy and chemotherapy combined with cisplatin, vindesine and mitomycin in non-small-cell lung cancer with brain metastasis.
por: Furuse, K., et al.
Publicado: (1997)

A Bayesian network meta-analysis of whole brain radiotherapy and stereotactic radiotherapy for brain metastasis
por: Yuan, Xi, et al.
Publicado: (2017)

Retrospective study of hypofractionated stereotactic radiotherapy combined with whole brain radiotherapy for patients with brain metastases
por: Xie, Xue-Yi, et al.
Publicado: (2022)

Transfer Learning Approach to Vascular Permeability Changes in Brain Metastasis Post-Whole-Brain Radiotherapy
por: Arledge, Chad A., et al.
Publicado: (2023)

Spine Stereotactic Body Radiotherapy Outcomes in Patients with Concurrent Brain Metastases
por: Colaco, Rovel J, et al.
Publicado: (2016)

Meta‐analysis of whole‐brain radiotherapy plus temozolomide compared with whole‐brain radiotherapy for the treatment of brain metastases from non‐small‐cell lung cancer
por: Xin, Yong, et al.
Publicado: (2018)

TRLS-09. RTOG1119: PHASE II RANDOMIZED STUDY OF WHOLE BRAIN RADIOTHERAPY / STEREOTACTIC RADIOSURGERY IN COMBINATION WITH CONCURRENT LAPATINIB IN PATIENTS WITH BRAIN METASTASIS FROM HER2-POSITIVE BREAST CANCER
por: Kim, In Ah, et al.
Publicado: (2019)

Single institutional outcomes of whole brain radiotherapy for metastatic melanoma brain metastases
por: Jiang, Cecilia, et al.
Publicado: (2021)

Automated field‐in‐field whole brain radiotherapy planning
por: Huang, Kai, et al.
Publicado: (2022)

In silico trial of simulation-free hippocampal-avoidance whole brain adaptive radiotherapy
por: Price, Alex T., et al.
Publicado: (2023)

Neurocognitive function impairment after whole brain radiotherapy for brain metastases: actual assessment
por: Tallet, Agnes V, et al.
Publicado: (2012)

Prospective memory impairment following whole brain radiotherapy in patients with metastatic brain cancer
por: Cheng, Huaidong, et al.
Publicado: (2018)

Does Time between Imaging Diagnosis and Initiation of Radiotherapy Impact Survival after Whole-Brain Radiotherapy for Brain Metastases?
por: Nieder, Carsten, et al.
Publicado: (2013)

Concurrent Afatinib and Whole-Brain Radiotherapy in Exon 19-del-EGFR Mutant Lung Adenocarcinoma: A Case Report and Mini Review of the Literature
por: Eze, Chukwuka, et al.
Publicado: (2017)

Dosimetric characterization of whole brain radiotherapy of pediatric patients using modulated proton beams
por: Jin, Hosang, et al.
Publicado: (2011)

Hippocampal‐sparing whole‐brain radiotherapy using the Elekta equipment
por: Nevelsky, Alexander, et al.
Publicado: (2013)

Clinical implementation of automated treatment planning for whole‐brain radiotherapy
por: Han, Eun Young, et al.
Publicado: (2021)

Dosimetric feasibility of hippocampal avoidance whole brain radiotherapy with an MRI‐guided linear accelerator
por: Graham, Jasmine A., et al.
Publicado: (2022)

Whole-Brain Radiotherapy vs. Localized Radiotherapy after Resection of Brain Metastases in the Era of Targeted Therapy: A Retrospective Study
por: Koo, Jaho, et al.
Publicado: (2021)

Randomized Trial of Erlotinib Plus Whole-Brain Radiotherapy for NSCLC Patients With Multiple Brain Metastases
por: Lee, Siow Ming, et al.
Publicado: (2014)

Palliative whole-brain radiotherapy and health- related quality of life for patients with brain metastasis in cancer
por: Gao, Ying, et al.
Publicado: (2015)

Upfront whole brain radiotherapy for multiple brain metastases in patients with EGFR-mutant lung adenocarcinoma
por: Li, Changhui, et al.
Publicado: (2019)

Re-Whole Brain Radiotherapy May Be One of the Treatment Choices for Symptomatic Brain Metastases Patients
por: Ono, Takashi, et al.
Publicado: (2022)

Efficacy and toxicity of whole brain radiotherapy in patients with multiple cerebral metastases from malignant melanoma
por: Hauswald, Henrik, et al.
Publicado: (2012)

A Dutch phase III randomized multicenter trial: whole brain radiotherapy versus stereotactic radiotherapy for 4–10 brain metastases
por: Hartgerink, Dianne, et al.
Publicado: (2021)

Dosimetric Study and Neurocognitive Function of Hippocampal-Sparing Whole-Brain Radiotherapy
por: Wang, Baohong, et al.
Publicado: (2017)

Debate: adjuvant whole brain radiotherapy or not? More data is the wiser choice
por: Fogarty, Gerald B., et al.
Publicado: (2016)

Automated contouring and planning pipeline for hippocampal-avoidant whole-brain radiotherapy
por: Feng, Christine H., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_l03j2dqc75nh949epg68b7rr07